BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 6421256)

  • 1. Weighted criteria for the diagnosis of systemic lupus erythematosus.
    Clough JD; Elrazak M; Calabrese LH; Valenzuela R; Braun WB; Williams GW
    Arch Intern Med; 1984 Feb; 144(2):281-5. PubMed ID: 6421256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defining lupus cases for clinical studies: the Boston weighted criteria for the classification of systemic lupus erythematosus.
    Costenbader KH; Karlson EW; Mandl LA
    J Rheumatol; 2002 Dec; 29(12):2545-50. PubMed ID: 12465149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoantibody determination in the diagnosis of systemic lupus erythematosus.
    Kurien BT; Scofield RH
    Scand J Immunol; 2006 Sep; 64(3):227-35. PubMed ID: 16918691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VH4-34 encoded antibodies in systemic lupus erythematosus: a specific diagnostic marker that correlates with clinical disease characteristics.
    van Vollenhoven RF; Bieber MM; Powell MJ; Gupta PK; Bhat NM; Richards KL; Albano SA; Teng NN
    J Rheumatol; 1999 Aug; 26(8):1727-33. PubMed ID: 10451069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Crithidia luciliae kinetoplast immunofluorescence test in systemic lupus erythematosus.
    Slater NG; Cameron JS; Lessof MH
    Clin Exp Immunol; 1976 Sep; 25(3):480-6. PubMed ID: 786521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laboratory procedures used in the diagnosis of systemic lupus erythematosus: a review.
    Gay L; Barr J
    Am J Med Technol; 1977 Sep; 43(9):856-63. PubMed ID: 73351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antibodies against native DNA. The methods for their demonstration. Their diagnostic and pathogenetic importance in systemic lupus erythematosus].
    Kostadinova DA; Razboĭnikov S
    Vutr Boles; 1976; 15(2):18-26. PubMed ID: 59467
    [No Abstract]   [Full Text] [Related]  

  • 8. [Comparison of severity and native anti-DNA antibody levels in systemic lupus erythematosus. Serodiscordant lupus].
    Manent-Ducreuzet C; Margulis J; Kahn MF
    Rev Rhum Mal Osteoartic; 1981 Nov; 48(11):705-12. PubMed ID: 6975965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Crithidia luciliae test in the diagnosis of systemic lupus erythematosus.
    Losito A; Zampi I; Bertotto A; Zucchetti P
    Ric Clin Lab; 1979; 9(2):141-5. PubMed ID: 388594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-nucleosome antibodies in patients with systemic lupus erythematosus of recent onset. Potential utility as a diagnostic tool and disease activity marker.
    Simón JA; Cabiedes J; Ortiz E; Alcocer-Varela J; Sánchez-Guerrero J
    Rheumatology (Oxford); 2004 Feb; 43(2):220-4. PubMed ID: 13130152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolated antinuclear antibody-negative lupus nephropathy in young children.
    Enriquez JL; Rajaraman S; Kalia A; Brouhard BH; Travis LB
    Child Nephrol Urol; 1988-1989; 9(6):340-6. PubMed ID: 3272856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of criteria contributions for the classification of systemic lupus erythematosus.
    Somogyi L; Cikes N; Marusić M
    Scand J Rheumatol; 1993; 22(2):58-62. PubMed ID: 8480139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Seronegative systemic lupus erythematosus (author's transl)].
    Goff PL; Youinou P; Le Menn G
    Sem Hop; 1981 Jun 18-25; 57(25-28):1217-20. PubMed ID: 6266042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Theoretical objective evaluation of the value of a diagnostic criterion. Application to antinuclear antibodies for the diagnosis of systemic lupus erythematosus].
    Vinceneux P; Yeni P; Boboc B; Carbon C
    Rev Rhum Mal Osteoartic; 1984 Oct; 51(9):493-6. PubMed ID: 6334353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The significance of discrepant Farr and Crithidia luciliae tests.
    McGuigan L; Edmonds J; Wellings G; Jones M
    J Rheumatol; 1984 Apr; 11(2):172-4. PubMed ID: 6610050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Borderline systemic lupus erythematosus (SLE): a separate entity or a forerunner to SLE?
    Al Attia HM
    Int J Dermatol; 2006 Apr; 45(4):366-9. PubMed ID: 16650159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lupus erythematosus latex tests compared with the immunofluorescence method for antinuclear factor.
    Chapman JC
    Am J Med Technol; 1976 May; 42(5):154-7. PubMed ID: 58558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Systemic lupus erythematosus and AIDS. Difficulties in the differential diagnosis].
    Montero A; Prato R; Jorfen M
    Medicina (B Aires); 1991; 51(4):303-6. PubMed ID: 1821918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lupus nephropathy as the initial manifestation of systemic lupus erythematosus.
    Lynn RI; Siegel NJ; Hayslett JP
    Yale J Biol Med; 1980; 53(5):353-9. PubMed ID: 6971530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-telomere antibodies in systemic lupus erythematosus (SLE): a comparison with five antinuclear antibody assays in 430 patients with SLE and other rheumatic diseases.
    Salonen EM; Miettinen A; Walle TK; Koskenmies S; Kere J; Julkunen H
    Ann Rheum Dis; 2004 Oct; 63(10):1250-4. PubMed ID: 15361381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.